Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis

Annals of Hematology

Volumn 93, Issue 9, 2014, Pages 1483-1489

  Juncà, Jordi ^a   Garcia Caro, Montse ^a   Granada, Isabel ^a   Rodríguez Hernández, Inés ^a   Torrent, Anna ^a   Morgades, Mireia ^a   Ribera, Josep Maria ^a   Millá, Fuensanta ^a   Feliu, Evarist ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Acute myeloid leukemia; CD11b; CD56; Cytogenetic risk group survival

Indexed keywords

CD11B ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ADULT DISEASE; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOGENETICS; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE FREQUENCY; GENETIC RISK; HIGH RISK POPULATION; HUMAN; IMMUNOPHENOTYPING; INTERMEDIATE RISK POPULATION; KARYOTYPE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD11B; ANTIGENS, CD56; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84905570172     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2082-4     Document Type: Article

References (23)

1. Mason KD, Juneja SK, Szer J (2006) The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis? Blood Rev 20:71-82
2. Ossenkoppele GJ, van de Loosdrecht AA, Schuurhuis GJ (2011) Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms. Br J Haematol 153:421-436
3. Yang DH, Lee JJ, Mun YC, Shin HJ, Kim YK, Cho SH et al (2007) Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stemcell transplantation. Am J Hematol 82:1-5
4. Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F et al (2000) CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. J Clin Oncol 18:1295-1300 (Pubitemid 30159848)
5. Raspadori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G et al (2001) CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 15:1161-1164 (Pubitemid 32776438)
6. Chang H, Salma F, Yi QL, Patterson B, Brien B, Minden MD (2004) Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. Leuk Res 28:43-48 (Pubitemid 37433792)
7. Jiang A, Jiang H, Brandwein J, Kamel-Reid S, Chang H (2011) Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation. Leuk Res 35:492-498
8. Dang H, Jiang A, Kamel-Reid S, Brandwein J, Chang H (2013) Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype. Hum Pathol 44:55-61
9. Iriyama N, Hatta Y, Takeuchi J, Ogawa Y, Ohtake S, Sakura T et al (2013) CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21). Leuk Res 37:1021-1026
10. Di Bona E, Sartori R, Zambello R, Guercini N, Madeo D, Rodeghiero F (2002) Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Haematologica 87:250-256 (Pubitemid 34212440)
11. Legrand O, Perrot JY, Baudard M, Cordier A, Lautier R, Simonin G et al (2000) The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood 96:870-877 (Pubitemid 30616850)
12. Tucker J, Dorey E, Gregory WM, Simpson AP, Amess JA, Lister TA et al (1990) Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome. Hematol Oncol 8:47-58
13. Bradstock K, Matthews J, Benson E, Page F, Bishop J (1994) Prognostic value of immunophenotyping in acute myeloid leukemia. Australian leukaemia study group. Blood 84:1220-1225 (Pubitemid 24245888)
14. Tien HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM et al (1995) Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet 84:60-68
15. Paietta E, Andersen J, Yunis J, Rowe JM, Cassileth PA, Tallman MS et al (1998) Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. eastern cooperative oncology group. Br J Haematol 100:265-272
16. Graf M, Reif S, Kroll T, Hecht K, Nuessler V, Schmetzer H (2006) Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis. Am J Hematol 81:227-235
17. Chen MH, Atenafu E, Craddock KJ, Brandwein J, Chang H (2013) CD11b expression correlates withmonosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia. Leuk Res 37:122-128
18. Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom medical research council trials. Blood 116:354-365
19. Swerdlow SH, International Agency for Research on Cancer (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer
20. Nomdedeu J, Bussaglia E, Villamor N, Martinez C, Esteve J, Tormo M et al (2011) Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size. Leuk Res 35:163-168
21. Shaffer LG, Slovak ML, Campbell LL. ISCN (2009) An international system for human cytogenetic nomenclature. Basel: Karger; 2009
22. Junca J, Granada I, Rodriguez-Hernandez I, Milla F (2013) CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavourable acute myeloid leukemia. Leuk Res 37:859-860
23. van Dongen JJ, Lhermitte L, Bottcher S, Almeida J, van der Velden VH, Flores-Montero J et al (2012) EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 26:1908-1975